The U.S. pet therapeutic diet market size was estimated at USD 1.47 billion in 2024 and is projected to reach USD 2.64 billion by 2033, growing at a CAGR of 6.71% from 2025 to 2033. Some of the key growth drivers for the market include the rising prevalence of chronic health conditions among pets, such as obesity, kidney disease, and gastrointestinal disorders.
Other factors, such as growing biotechnological innovations efforts in pet nutrition, efforts for educational awareness, a rise in pet insurance coverage for prescription foods, and pet humanization, where owners seek specialized, vet-recommended nutrition, are also expected to further fuel the growth. Nestlé, a key leading player in this industry, in May 2025, unveiled a major enhancement of its R&D capabilities, specifically emphasizing biotechnology, clinical research, and deep technology, to advance precision nutrition and pet therapeutics. This strategic initiative incorporates cutting-edge methodologies such as precision fermentation, screening assays, and development of biotics, including next-generation postbiotics and synbiotics. These advances are designed to yield scientifically validated ingredients with proven bio-efficacy. They enable highly targeted nutritional solutions tailored to pets throughout their lifespan-from early life and healthy aging to therapeutic diet applications.
By streamlining its R&D structure and prioritizing high-impact projects in close alignment with commercial teams, the company aims to accelerate innovation efficiency and responsiveness. Such intensified investments in biotech and clinical research signal a push into the expanding functional and therapeutic pet nutrition sector, reflecting rising consumer demand for science-backed, health-oriented pet diets. Given the company’s standing as a leading player in the global pet care industry, these innovation efforts are likely to influence market dynamics strongly in the U.S. pet therapeutic diet segment, driving growth and setting new expectations for evidence-based dietary products designed to manage or prevent health conditions in pets.
This product will be delivered within 1-3 business days.
Other factors, such as growing biotechnological innovations efforts in pet nutrition, efforts for educational awareness, a rise in pet insurance coverage for prescription foods, and pet humanization, where owners seek specialized, vet-recommended nutrition, are also expected to further fuel the growth. Nestlé, a key leading player in this industry, in May 2025, unveiled a major enhancement of its R&D capabilities, specifically emphasizing biotechnology, clinical research, and deep technology, to advance precision nutrition and pet therapeutics. This strategic initiative incorporates cutting-edge methodologies such as precision fermentation, screening assays, and development of biotics, including next-generation postbiotics and synbiotics. These advances are designed to yield scientifically validated ingredients with proven bio-efficacy. They enable highly targeted nutritional solutions tailored to pets throughout their lifespan-from early life and healthy aging to therapeutic diet applications.
By streamlining its R&D structure and prioritizing high-impact projects in close alignment with commercial teams, the company aims to accelerate innovation efficiency and responsiveness. Such intensified investments in biotech and clinical research signal a push into the expanding functional and therapeutic pet nutrition sector, reflecting rising consumer demand for science-backed, health-oriented pet diets. Given the company’s standing as a leading player in the global pet care industry, these innovation efforts are likely to influence market dynamics strongly in the U.S. pet therapeutic diet segment, driving growth and setting new expectations for evidence-based dietary products designed to manage or prevent health conditions in pets.
U.S. Pet Therapeutic Diet Market Report Segmentation
This report forecasts revenue growth and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. The analyst has segmented the U.S. pet therapeutic diet market report based on product, pet, indication, and distribution channel:Product Outlook (Revenue, USD Million, 2021-2033)
- Wet Food
- Dry Food
- Other products
Pet Outlook (Revenue, USD Million, 2021-2033)
- Dogs
- Cats
- Other Pets
Indication Outlook (Revenue, USD Million, 2021-2033)
- Renal Care
- Obesity Care
- Diabetic Care
- Dental Care
- Gastrointestinal Care
- Recovery Care
- Joint Care
- Oncology Care
- Others
Distribution Channel Outlook (Revenue, USD Million, 2021-2033)
- E-commerce
- Veterinary hospitals & clinics
- Supermarkets/Hypermarkets
- Others
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the industry across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segmental and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. U.S. Pet Therapeutic Diet Market Variables, Trends, & Scope
Chapter 4. U.S. Pet Therapeutic Diet Market: Product Estimates & Trend Analysis
Chapter 5. U.S. Pet Therapeutic Diet Market: Pet Estimates & Trend Analysis
Chapter 6. U.S. Pet Therapeutic Diet Market: Indication Estimates & Trend Analysis
Chapter 7. U.S. Pet Therapeutic Diet Market: Distribution Channel Estimates & Trend Analysis
Chapter 8. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
The major companies profiled in this U.S. Pet Therapeutic Diet market report include:- Colgate-Palmolive Company (Hill's Pet Nutrition Inc.)
- Nestlé
- Mars Petcare (Royal Canin)
- General Mills Inc. (Blue Buffalo Company, Ltd.)
- Diamond Pet Foods, Inc.
- Virbac
- Farmina Pet Foods
- JustFoodForDogs
- EmerAid, LLC
- Merrick Pet Care
- The Farmer’s Dog, Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 150 |
| Published | August 2025 |
| Forecast Period | 2024 - 2033 |
| Estimated Market Value ( USD | $ 1.47 Billion |
| Forecasted Market Value ( USD | $ 2.64 Billion |
| Compound Annual Growth Rate | 6.7% |
| Regions Covered | United States |
| No. of Companies Mentioned | 12 |
